Prognostic implications of RAS alterations in diverse malignancies and impact of targeted therapies.
Kato S, Okamura R, Sicklick JK, Daniels GA, Hong DS, Goodman A, Weihe E, Lee S, Khalid N, Collier R, Mareboina M, Riviere P, Whitchurch TJ, Fanta PT, Lippman SM, Kurzrock R.
Kato S, et al. Among authors: riviere p.
Int J Cancer. 2020 Jun 15;146(12):3450-3460. doi: 10.1002/ijc.32813. Epub 2020 Jan 29.
Int J Cancer. 2020.
PMID: 31782524
Free PMC article.